GenoGra

GenoGra

Private
MilanHealthcare & Life Scienceshttps://genogra.com/

Last Round

Pre Seed

Feb 16, 2026

Total Funding Raised

$1.19M

Momentum Score

75 /100

Company Overview

GenoGra is a biotechnology company that develops a pangenomic software platform designed for faster and more accurate interpretation of genetic data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

pangenomic analysisgenome graphspangenome softwarebioinformatics platformnon-human genomicspangenome graphsgenome graph analysispopulation genomicsgenomic data analysisagricultural genomicslivestock genomicsgenomic analysis softwaregenomic data visualizationclinical genomicsprecision medicineindustrial microbiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenoGra Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenoGra Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 16, 2026

Key People

Founding team and executive leadership

Guido Walter Di Donato

Chief Executive Officer & Founder

Founding Team

Alessandro Vingione

Chief Operating Officer, Board Member

Executive Team

GenoGra Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 63% QoQ, from 8 to 13 employees.

  • Apr 6, 2026

    Monthly visitors increased 191% MoM.

GenoGra Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenoGra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenoGra's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan
Employee Range13
Year Founded2023
Last FundingFeb 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.